Published in Br Med J on February 08, 1975
Tardive dyskinesia associated with metoclopramide. Br Med J (1978) 1.33
Letter: Involuntary facial movements. Br Med J (1975) 0.75
Dystonic reactions in children caused by metoclopramide. Arch Dis Child (1970) 4.80
Cutaneous involvement in erythroleukemia. Report of a case. Dermatologica (1974) 1.14
[Apropos of a suicide attempt without untoward effects with methochlopramide]. Therapie (1966) 1.13
Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1997) 2.90
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet (2000) 2.39
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab (2000) 2.27
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial. J Clin Endocrinol Metab (2010) 2.16
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A (1999) 2.04
Interaction between warfarin sodium and amiodarone. N Engl J Med (1981) 1.88
Clonal origin of pituitary adenomas. J Clin Endocrinol Metab (1990) 1.81
Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1999) 1.78
Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab (1998) 1.74
Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med (1999) 1.72
Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab (1999) 1.69
Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.68
Colon polyps in acromegaly. Ann Intern Med (1991) 1.66
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol (2001) 1.61
Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J Clin Endocrinol Metab (1998) 1.48
Clinical, quality of life, and economic value of acromegaly disease control. Pituitary (2011) 1.44
Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab (2000) 1.41
Human fetal pituitary expresses functional growth hormone-releasing peptide receptors. J Clin Endocrinol Metab (1998) 1.38
Pathophysiology of acromegaly. Endocr Rev (1983) 1.35
Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology (1998) 1.33
Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev (2000) 1.28
Morphology of a naphthalene-induced bronchiolar lesion. Am J Pathol (1977) 1.25
Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. J Biol Chem (2000) 1.24
Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest (2000) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21
Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology (1998) 1.19
Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab (1999) 1.18
Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci U S A (1994) 1.18
Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest (1999) 1.17
Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab (2001) 1.17
An unusual case of empyema; intrapleural migration of an inhaled oat head in an adult. Thorac Cardiovasc Surg (1983) 1.14
Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest (1996) 1.14
Visualization of freezing damage. II. Structural alterations during warming. Cryobiology (1973) 1.12
Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology (1987) 1.11
Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol (1998) 1.11
Visualization of freezing damage. J Cell Biol (1973) 1.11
Structural analyses on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev Biol (1978) 1.10
Pituitary cytokine and growth factor expression and action. Endocr Rev (1997) 1.10
Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10
Somatotroph insulin-like growth factor-I signaling. Ann N Y Acad Sci (1993) 1.09
Management of pituitary tumors. Ann Intern Med (1998) 1.07
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab (1991) 1.07
Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest (1995) 1.07
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest (1997) 1.06
Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene (2007) 1.06
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation (1982) 1.05
Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Mol Endocrinol (2000) 1.05
Angiographic diagnosis and differential diagnosis of islet-cell tumors. Am J Roentgenol Radium Ther Nucl Med (1973) 1.01
Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology (1996) 1.01
Propylthiouracil-induced hepatic damage. Arch Intern Med (1980) 1.00
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res (1995) 1.00
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab (1994) 1.00
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. J Clin Endocrinol Metab (1995) 1.00
Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J Biol Chem (1999) 1.00
The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest (2001) 1.00
Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab (1994) 0.99
Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest (1987) 0.99
The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription. Biol Chem (2001) 0.98
Oncogene activation in pituitary tumors. Brain Pathol (2001) 0.97
Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med (1985) 0.97
Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression. J Clin Endocrinol Metab (2012) 0.97
Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology (1986) 0.96
Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest (1997) 0.96
Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab (1993) 0.95
Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology (1992) 0.95
Sistr Joseph's nodule and malignant ascites in multiple myeloma. N Engl J Med (1971) 0.95
Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology (1999) 0.94
Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors. J Endocrinol (1998) 0.93
Pituitary tumor transforming gene 1 regulates Aurora kinase A activity. Oncogene (2008) 0.92
A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem (1997) 0.92
Insulin regulation of rat growth hormone gene transcription. J Clin Invest (1986) 0.92
Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination. Eur J Clin Pharmacol (1985) 0.92
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest (2008) 0.92
cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. Mol Endocrinol (2001) 0.91
Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med (1986) 0.91
Spinal epidural abscess: an unusual complication of bacterial endocarditis. Infection (1984) 0.91
Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab (1993) 0.90
Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest (1984) 0.90
Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. Mol Endocrinol (2006) 0.90
Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies. J Urol (1995) 0.90
A comparison of methods for assessing thyroid function in nonthyroidal illness. J Clin Endocrinol Metab (1982) 0.90
Diagnosis and treatment of acromegaly complications. J Endocrinol Invest (2003) 0.90
Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. Mol Endocrinol (1998) 0.90
Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. J Clin Endocrinol Metab (1998) 0.89
Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab (1998) 0.89
Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest (1997) 0.89
Cardiac morphology in rats with growth hormone-producing tumours. J Mol Cell Cardiol (1985) 0.88
Glutathione-dependent thyroxine 5'-monodeiodination modulates growth hormone production by cultured nonthyrotropic rat pituitary cells. Endocrinology (1981) 0.88
H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab (1994) 0.88
Myoinositol in human neonates: serum concentrations and renal handling. Pediatr Res (1978) 0.88
An assay of the antithrombotic action of warfarin: its correlation with the inhibition of stasis thrombosis in rabbits. Thromb Haemost (1979) 0.87
Proteasome inhibitors induce apoptosis in growth hormone- and prolactin-secreting rat pituitary tumor cells. J Endocrinol (2002) 0.87
Effects of malaria (Plasmodium berghei) on the maternal-fetal relationship in mice. J Protozool (1982) 0.87
An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. J Clin Endocrinol Metab (1999) 0.87